Medgene Announces USDA Approval at ISU Research Park
Warning! Your browser is extremely outdated and not web standards compliant.
Your browsing experience would greatly improve by upgrading to a modern browser.

Medgene announced USDA Platform Vaccines approval during an event at the ISU Research Park 

The USDA Center for Veterinary Biologics (CVB) has allowed animal health company, Medgene, license to produce and market a USDA - approved category of vaccines called Platform Vaccines to the cattle industry. Specific cattle vaccines available under this new Platform Vaccine category include Influenza D, Coronavirus, Rotavirus, and Papillomavirus.

Medgene’s vaccine approaches leverage USDA-approved “platform technology” guidelines that are safe, and easily adapted to multiple animal disease targets. The result is the development of vaccines and an understanding of how diseases move across species and geographies within a fraction of the time of traditional vaccine approaches.

Dr. Alan Young, Chief Technology Officer for Medgene, began foundational work in Platform Vaccine technology in 2010. “Vaccines have come a long, long way since their first use in the late 1700s. We’ve learned that diseases, no matter what the species, have a lot in common. But by focusing on the unique genetic components that are different, we can create vaccines that are far more efficient.”

Read the full announcement.

Published June 2023 by Medgene.

Related Articles